FGF21 and metabolic dysfunction-associated steatotic liver disease: Our present data on serum FGF21 levels is also in line with the earlier study in humans which showed that hepatic FGF21 mRNA expression was significantly elevated in NAFLD patients and it correlated with a substantial increase in serum FGF21 in these patients [49].